ENDRA Life Sciences Inc. (NDRA) Operating income 2016–2025
ENDRA Life Sciences Inc. (NDRA) annual operating income history from SEC filings — each fiscal year as reported.
-$5.8MFY2025 · since FY2016: -$1.8M → -$5.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.8M | +46.7% |
| FY2024 | -$10.8M | -2.8% |
| FY2023 | -$10.5M | +20.0% |
| FY2022 | -$13.2M | -14.4% |
| FY2021 | -$11.5M | +0.0% |
| FY2020 | -$11.5M | -6.1% |
| FY2019 | -$10.8M | -20.2% |
| FY2018 | -$9.0M | -95.0% |
| FY2017 | -$4.6M | -158.2% |
| FY2016 | -$1.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice